These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23336155)

  • 21. Physiologic response of human brain death and the use of vasopressin for successful organ transplantation.
    Nakagawa K; Tang JF
    J Clin Anesth; 2011 Mar; 23(2):145-8. PubMed ID: 21377081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of hormonal therapy in improving organ viability in the transplant donor.
    Novitzky D; Cooper DK; Reichart B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2037-8. PubMed ID: 3079070
    [No Abstract]   [Full Text] [Related]  

  • 23. Results of hormonal therapy in human brain-dead potential organ donors.
    Novitzky D; Cooper DK
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):59-62. PubMed ID: 3055561
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of the heartbeating brain-dead organ donor.
    McKeown DW; Bonser RS; Kellum JA
    Br J Anaesth; 2012 Jan; 108 Suppl 1():i96-107. PubMed ID: 22194439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.
    Jeevanandam V; Todd B; Regillo T; Hellman S; Eldridge C; McClurken J
    J Heart Lung Transplant; 1994; 13(4):681-7; discussion 685-7. PubMed ID: 7947885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One Heart for Two Recipients: An Effective Option to Increase Donor Organ Availability in Heart Transplantation.
    Rodríguez-González E; Hernández-Pérez FJ; Gómez-Bueno M; Segovia J; Forteza A; Alonso-Pulpón L
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1220-1221. PubMed ID: 27522276
    [No Abstract]   [Full Text] [Related]  

  • 27. [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model].
    Ojeda Rivero R; Cerro Sánchez J; Ordóñez Fernández A; Domínguez Roldán JM; Hernández Fernández A
    Rev Esp Anestesiol Reanim; 2002 May; 49(5):229-37. PubMed ID: 12216505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor hearts with impaired hemodynamics. Benefit of warm substrate-enriched blood cardioplegic solution for induction of cardioplegia during cardiac harvesting.
    Tixier D; Matheis G; Buckberg GD; Young HH
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):207-13; discussion 213-4. PubMed ID: 1678027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How France launched its donation after cardiac death program.
    Antoine C; Mourey F; Prada-Bordenave E;
    Ann Fr Anesth Reanim; 2014 Feb; 33(2):138-43. PubMed ID: 24388490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of donor cardiac function for heart transplantation: experience of a French academic hospital.
    Boudaa C; Lalot JM; Perrier JF; Voltz C; Strub P; Claudon O; Audibert G; Sandefo I; Meistelman C; Longrois D; Mertes PM
    Ann Transplant; 2000; 5(4):51-3. PubMed ID: 11499362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart.
    Cooper DK; Novitzky D; Wicomb WN
    Ann R Coll Surg Engl; 1989 Jul; 71(4):261-6. PubMed ID: 2774455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical management to optimize donor organ potential: review of the literature.
    Kutsogiannis DJ; Pagliarello G; Doig C; Ross H; Shemie SD
    Can J Anaesth; 2006 Aug; 53(8):820-30. PubMed ID: 16873350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-heart-beating donation: ethical aspects.
    Vincent JL; Brimioulle S
    Transplant Proc; 2009 Mar; 41(2):576-8. PubMed ID: 19328929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors.
    Bittner HB; Kendall SW; Chen EP; Davis RD; Van Trigt P
    Ann Thorac Surg; 1995 Jul; 60(1):47-54. PubMed ID: 7598620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplanting hearts after death measured by cardiac criteria: the challenge to the dead donor rule.
    Veatch RM
    J Med Philos; 2010 Jun; 35(3):313-29. PubMed ID: 20439354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique.
    Wheeldon DR; Potter CD; Oduro A; Wallwork J; Large SR
    J Heart Lung Transplant; 1995; 14(4):734-42. PubMed ID: 7578183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal therapy in the brain-dead experimental animal.
    Cooper DK; Novitzky D; Wicomb WN
    Transplant Proc; 1988 Oct; 20(5 Suppl 7):51-4. PubMed ID: 3055559
    [No Abstract]   [Full Text] [Related]  

  • 38. Management to optimize organ procurement in brain dead donors.
    Mascia L; Mastromauro I; Viberti S; Vincenzi M; Zanello M
    Minerva Anestesiol; 2009 Mar; 75(3):125-33. PubMed ID: 18636057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early donor management increases the retrieval rate of hearts for transplantation in marginal donors.
    Abuanzeh R; Hashmi F; Dimarakis I; Khasati N; Machaal A; Yonan N; Venkateswaran RV
    Eur J Cardiothorac Surg; 2015 Jan; 47(1):72-7; discussion 77. PubMed ID: 24699201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor brain death time and impact on outcomes in heart transplantation.
    Marasco S; Kras A; Schulberg E; Vale M; Chan P; Lee GA; Bailey M
    Transplant Proc; 2013; 45(1):33-7. PubMed ID: 23375272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.